Perth-based biotechnology company Xceed Capital Ltd will net over $6 million in scrip from selling its majority shareholding in PolyNovo Biomaterials Ltd to a Melbourne company.

Perth-based biotechnology company Xceed Capital Ltd will net over $6 million in scrip from selling its majority shareholding in PolyNovo Biomaterials Ltd to a Melbourne company.